Taipei, Taipei City, Taiwan
I am a dedicated venture capital (VC) investment professional specializing in biotech and pharmaceutical investments. With a strong background in drug development, market analysis, and licensing, I bring deep expertise in evaluating innovative technologies, identifying high-potential investment opportunities, and conducting comprehensive due diligence to inform strategic investment decisions. My experience includes hands-on involvement in innovative drug development, analyzing new drug pipelines, platform technologies, and intellectual property (IP) landscapes. This enables me to evaluate scientific breakthroughs and commercial potential. I’ve also successfully led licensing negotiations and closed technology-specific deals under tight deadlines, demonstrating my ability to drive high-impact investment decisions. What sets me apart is my ability to integrate scientific, clinical, and market insights to evaluate biotech startups and emerging therapeutic platforms. I specialize in developing investment theses, conducting risk assessments, and identifying unmet medical needs to support high-value investment strategies. In the near term, I aim to deepen my expertise in emerging therapeutic areas. Over time, my goal is to help bring groundbreaking therapies to market by leveraging strategic vision, industry expertise, and a strong analytical approach. If you’re looking for a partner who combines industry knowledge with a passion for advancing biotech innovation, I’d be happy to explore how we can create meaningful progress together.
(1) Analyzed new biotech pipelines to forecast investment potential. (2) Conducted due diligence to inform strategic investment decisions. (3) Leveraged market trends and scientific insight to identify high-value investment opportunities.
(1) Strategic planning for new drug development (2) Expertly analyze new pharmaceuticals or technologies across multiple domains (3) Experienced in licensing terms and conditions planning, negotiation, contract drafting, and execution
(1) Actively seeks out potential licensees and negotiates Out-License terms (2) Establishes collaborative relationships with industry partners (3) Conducts technology evaluation, including competition and patent landscape analyses (4) Completed 26 biomedical market analyses encompassing the markets of antibodies, peptides, small molecules, vaccines, microbiota, cell therapy, nanoparticles, liposomes and biomarkers (5) Giving advices on patentability; Strategizing the patent prosecution; Instructing patent attorneys of both domestic and foreign law firms (6) Participated in the BIO international conferences & Organized the presentation of the technologies for promotion
(1) Identified and designed translational animal models to evaluate biological and pharmacological functions of a therapeutic oncolytic virus product (2) Assisted with the CMC development of a biosimilar antibody, and monitored project progress
Led a team to investigate the protective efficacy and immune responses of an influenza B virus vaccine in mouse and ferret models